Technology
Health
Biotechnology

Voyager Therapeutics

1,212

$9.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (+2.75%) As of 1:56 PM EDT today
+$0.24 (+2.75%) Today

Why Robinhood?

You can buy or sell VYGR and other stocks, options, ETFs, and crypto commission-free!

About VYGR

Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. Read More The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

CEO
G. Andre Turenne
Employees
185
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
302.05M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
450.86K
High Today
$9.54
Low Today
$8.85
Open Price
$9.04
Volume
368.46K
52 Week High
$28.79
52 Week Low
$6.26

Collections

Technology
Health
Biotechnology
Therapy
Medical
2015 IPO
US
North America

VYGR Earnings

-$0.81
-$0.35
$0.12
$0.58
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, Pre-Market

People Also Bought

Viking Therapeutics

52,601

$4.82

+3.66%

Viking Therapeutics

52,601

$4.82

+3.66%

CRISPR

29,879

$43.46

+3.05%

Editas Medicine

10,328

$21.45

+0.47%

Sangamo Therapeutics

7,470

$6.91

+1.99%

You May Also Like

STOR
MHF
EPR
LVHB
UBCP
CUZ
WM
IYK
PEK
EEMD
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy VYGR

Market Price$9.16
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell VYGR stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up